Panel Discussion: Evaluating Investor Interest in Next-Generation Gene Therapy Technologies
Time: 4:30 pm
day: Conference Day One
Details:
- What innovation in gene therapy vector development makes for an attractive investment proposition?
- What differentiating factors and data packages are big pharma looking for to acquire or collaborate with new startups?
- Looking beyond rare disease: are investors confident that better delivery tools could enable gene therapy success in more prevalent conditions?
Speakers:
